Thymoquinone restores radiation-induced TGF-β expression and abrogates EMT in chemoradiotherapy of breast cancer cells

Journal of Cellular Physiology

Volumn 230, Issue 3, 2015, Pages 620-629

  Rajput, Shashi ^a   Kumar, B N Prashanth ^a   Banik, Payel ^a   Parida, Sheetal ^a   Mandal, Mahitosh ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD51 ANTIGEN; CYTOKERATIN 19; GELATINASE A; GELATINASE B; PACLITAXEL; RADIOSENSITIZING AGENT; THYMOQUINONE; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; BENZOQUINONE DERIVATIVE;

APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL INVASION; CELL MIGRATION; CELL TRANSDIFFERENTIATION; CHEMORADIOTHERAPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; BREAST NEOPLASMS; DRUG EFFECTS; FEMALE; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BENZOQUINONES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL TRANSDIFFERENTIATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; PACLITAXEL; RADIATION; RADIOTHERAPY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84920868180     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24780     Document Type: Article

References (54)

1. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE. 2005. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11:7490-7498.
2. Andarawewa KL, Costes SV, Fernandez-Garcia I, Chou WS, Ravani SA, Park H, Barcellos-Hoff MH. 2011. Lack of radiation dose or quality dependence of epithelial-to-mesenchymal transition (EMT) mediated by transforming growth factor beta. Int J Radiat Oncol Biol Phys 79:1523-1531.
3. Barcellos-Hoff MH. 1993. Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res 53:3880-3886.
4. Baskar R, Lee KA, Yeo R, Yeoh KW. 2012. Cancer and radiation therapy: Current advances and future directions. Int J Med Sci 9:193-199.
5. Bhola NE, Balko JM, Dugger TC, Kuba MG, Sanchez V, Sanders M, Stanford J, Cook RS, Arteaga CL. 2013. TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer. J Clin Invest 123:1348-1358.
6. Biswas S, Guix M, Rinehart C, Dugger TC, Chytil A, Moses HL, Freeman ML, Arteaga CL. 2007. Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest 117:1305-1313.
7. Boothe DL, Coplowitz S, Greenwood E, Barney CL, Christos PJ, Parashar B, Nori D, Chao KSC, Wernicke AG. 2013. Transforming growth factor β-1 (TGF-β1) is a serum biomarker of radiation induced fibrosis in patients treated with intracavitary accelerated partial breast irradiation: Preliminary results of a prospective study. Int J Rad Oncol Biol Phys 87:1030-1036.
8. Boudreau HE, Casterline BW, Rada B, Korzeniowska A, Leto TL. 2012. Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to-mesenchymal transition and migration of breast epithelial cells. Free Radic Biol Med 53:1489-1499.
9. Bouquet F, Pal A, Pilones KA, Demaria S, Hann B, Akhurst RJ, Babb JS, Lonning SM, DeWyngaert JK, Formenti SC, Barcellos-Hoff MH. 2011. TGF beta 1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clin Cancer Res 17:6754-6765.
10. Camphausen K, Tofilon PJ. 2004. Combining radiation and molecular targeting in cancer therapy. Cancer Biol Ther 3:247-250.
11. Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM. 2004. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23:1599-1607.
12. Choy H, Akerley W, Safran H, Clark J, Rege V, Papa A, Glantz M, Puthawala Y, Soderberg C, Leone L. 1994. Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer. J Clin Oncol 12:2682-2686.
13. Dai Y, Desano J, Qu Y, Tang W, Meng Y, Lawrence TS, Xu L. 2011. Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer. Am J Cancer Res 1:128-143.
14. Dancea HC, Shareef MM, Ahmed MM. 2009. Role of radiation-induced TGF-beta signaling in cancer therapy. Mol Cell Pharmacol 1:44-56.
15. Dash R, Mandal M, Ghosh SK, Kundu SC. 2008. Silk sericin protein of tropical tasar silkworm inhibits UVB-induced apoptosis in human skin keratinocytes. Mol Cell Biochem 311:111-119.
16. Davidson NG. 1996. Single-agent paclitaxel as first-line treatment of metastatic breast cancer: The British experience. Semin Oncol 23:6-10.
17. Demicheli R, Retsky MW, Hrushesky WJ, Baum M, Gukas ID. 2008. The effects of surgery on tumor growth: A century of investigations. Ann Oncol 19:1821-1828.
18. Dhasarathy A, Phadke D, Mav D, Shah RR, Wade PA. 2011. The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer. PLoS One 6:e26514.
19. Drabsch Y, ten Dijke P. 2011. TGF-beta signaling in breast cancer cell invasion and bone metastasis. J Mammary Gland Biol Neoplasia 16:97-108.
20. Fang Y, DeMarco VG, Nicholl MB. 2012. Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci 103:1090-1098.
21. Gali-Muhtasib H, Roessner A, Schneider-Stock R. 2006. Thymoquinone: A promising anti-cancer drug from natural sources. Int J Biochem Cell B 38:1249-1253.
22. Gandhi NM, Nair CK. 2005. Protection of DNA and membrane from gamma radiation induced damage by gallic acid. Mol Cell Biochem 278:111-117.
23. Girdhani S, Bhosle SM, Thulsidas SA, Kumar A, Mishra KP. 2005. Potential of radiosensitizing agents in cancer chemo-radiotherapy. J Cancer Res Ther 1:129-131.
24. Guarino M. 2007. Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol 39:2153-2160.
25. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T. 2004. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114:569-581.
26. Itoh Y, Fuwa N, Morita K. 2003. Radiation therapy for metastatic brain tumors from lung cancer-A review to devise individualized treatment plans. Nagoya J Med Sci 66:119-128.
27. Javvadi P, Segan AT, Tuttle SW, Koumenis C. 2008. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol Pharmacol 73:1491-1501.
28. Jung S, Lee S, Lee J, Li C, Ohk JY, Jeong HK, Lee S, Kim S, Choi Y, Kim S, Lee H, Lee MS. 2012. Protein expression pattern in response to ionizing radiation in MCF-7 human breast cancer cells. Oncol Lett 3:147-154.
29. Kawamoto A, Yokoe T, Tanaka K, Saigusa S, Toiyama Y, Yasuda H, Inoue Y, Miki C, Kusunoki M. 2012. Radiation induces epithelial-mesenchymal transition in colorectal cancer cells. Oncol Rep 27:51-57.
30. Kumar BN, Rajput S, Dey KK, Parekh A, Das S, Mazumdar A, Mandal M. 2013. Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling. BMC Cancer 13:273.
31. Landauer MR, Srinivasan V, Seed TM. 2003. Genistein treatment protects mice from ionizing radiation injury. J Appl Toxicol 23:379-385.
32. Lv ZD, Kong B, Li JG, Qu HL, Wang XG, Cao WH, Liu XY, Wang Y, Yang ZC, Xu HM, Wang HB. 2013. Transforming growth factor-beta 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Oncol Rep 29:219-225.
33. Murphy DA, Makonnen S, Lassoued W, Feldman MD, Carter C, Lee WMF. 2006. Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006). Am J Pathol 169:1875-1885.
34. Nakayama S, Torikoshi Y, Takahashi T, Yoshida T, Sudo T, Matsushima T, Kawasaki Y, Katayama A, Gohda K, Hortobagyi GN, Noguchi S, Sakai T, Ishihara H, Ueno NT. 2009. Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells. Breast Cancer Res 11:R12.
35. Nejjari M, Hafdi Z, Gouysse G, Fiorentino M, Beatrix O, Dumortier J, Pourreyron C, Barozzi C, D'Errico A, Grigioni WF, Scoazec JY. 2002. Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study. Hepatology 36:418-426.
36. Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng YG, Krummen L, Winkler M, Ferrara N. 1997. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57:4593-4599.
37. Rajput S, Kumar BN, Dey KK, Pal I, Parekh A, Mandal M. 2013a. Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. Life Sci 93:783-790.
38. Rajput S, Kumar BN, Sarkar S, Das S, Azab B, Santhekadur PK, Das SK, Emdad L, Sarkar D, Fisher PB, Mandal M. 2013b. Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer. PLoS One 8:e61342.
39. Rajput S, Mandal M. 2012. Antitumor promoting potential of selected phytochemicals derived from spices: A review. Eur J Cancer Prev 21:205-215.
40. Ruegg C, Monnier Y, Kuonen F, Imaizumi N. 2011. Radiation-induced modifications of the tumor microenvironment promote metastasis. Bull Cancer 98:47-57.
41. Samatov TR, Tonevitsky AG, Schumacher U. 2013. Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds. Mol Cancer 12:107.
42. Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, Mandal M. 2010. ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells. Cancer Biol Ther 9:592-603.
43. Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, Mandal M. 2011. ZD6474 enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma cells. J Cell Physiol 226:375-384.
44. Sehrawat A, Singh SV. 2011. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells. Cancer Prev Res (Phila) 4:1107-1117.
45. Sethi G, Ahn KS, Aggarwal BB. 2008. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res 6:1059-1070.
46. Shoieb AM, Elgayyar M, Dudrick PS, Bell JL, Tithof PK. 2003. In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol 22:107-113.
47. Smith BD, Buchholz TA. 2013. Radiation treatments after breast-conserving therapy for elderly patients. J Clin Oncol 31:2367-2368.
48. Sofia Vala I, Martins LR, Imaizumi N, Nunes RJ, Rino J, Kuonen F, Carvalho LM, Ruegg C, Grillo IM, Barata JT, Mareel M, Santos SC. 2010. Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis. PLoS One 5:e11222.
49. Vellon L, Menendez JA, Liu H, Lupu R. 2007. Up-regulation of alphavbeta3 integrin expression is a novel molecular response to chemotherapy-induced cell damage in a heregulin-dependent manner. Differentiation 75:819-830.
50. Venkatesan P, Bhutia SK, Singh AK, Das SK, Dash R, Chaudhury K, Sarkar D, Fisher PB, Mandal M. 2012. AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells. Life Sci 91:789-799.
51. Venkatesan P, Puvvada N, Dash R, Prashanth Kumar BN, Sarkar D, Azab B, Pathak A, Kundu SC, Fisher PB, Mandal M. 2011. The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer. Biomaterials 32:3794-3806.
52. Yi T, Cho SG, Yi Z, Pang X, Rodriguez M, Wang Y, Sethi G, Aggarwal BB, Liu M. 2008. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther 7:1789-1796.
53. Zhang X, Li Y, Zhang Y, Song J, Wang Q, Zheng L, Liu D. 2013. Beta-elemene blocks epithelial-mesenchymal transition in human breast cancer cell line MCF-7 through Smad3-mediated down-regulation of nuclear transcription factors. PLoS One 8:e58719.
54. Zhang X, Li X, Zhang N, Yang Q, Moran MS. 2011. Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial-mesenchymal transition. Biochem Biophys Res Commun 412:188-192.